Your session is about to expire
← Back to Search
Collaborative Care for Depression in HIV Clinics (HITIDES-H3 Trial)
N/A
Waitlist Available
Led By Jacob T Painter, PhD PharmD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
HITIDES-H3 Trial Summary
This trial studies ways to better connect Veterans living with HIV to a depression care service that is more effective than regular care and saves resources.
Who is the study for?
This trial is for Veterans Living with HIV (VLWH) who are experiencing depression. Eligible VA clinics must have more than 20 VLWH, data on depression prevalence, a clinical champion to lead implementation, and willingness to participate. They should also offer diverse clinic characteristics like referral rates to mental health services.Check my eligibility
What is being tested?
The study tests two methods of integrating HITIDES—a service managing depression in VLWH—into VA clinics. One method involves an internal clinical champion supported by a network; the other adds an external expert facilitator. The impact on patient care and costs will be evaluated.See study design
What are the potential side effects?
Since this trial focuses on implementing a care model rather than testing medications or medical procedures, traditional side effects are not applicable. However, there may be indirect impacts on patients' experiences based on how well the service is integrated into their care.
HITIDES-H3 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Adoption
Cost - Budget Impact
Depression - Patient Health Questionnaire-9
+2 moreHITIDES-H3 Trial Design
2Treatment groups
Experimental Treatment
Group I: Implementation strategy bundle 2Experimental Treatment3 Interventions
Local clinical champion, learning collaborative, and external facilitation.
Group II: Implementation strategy bundle 1Experimental Treatment2 Interventions
Local clinical champion and learning collaborative.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,595 Total Patients Enrolled
Jacob T Painter, PhD PharmDPrincipal InvestigatorCentral Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.My site has the necessary data to check for depression.
Research Study Groups:
This trial has the following groups:- Group 1: Implementation strategy bundle 1
- Group 2: Implementation strategy bundle 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for new participants to join this research endeavor?
"The trial in question, which was initially posted on April 1st 2024 and had its last update recorded on June 2nd 2023, has now ceased recruitment of patients. Nevertheless, there are still 1580 other trials that are currently seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger